Celldex Therapeutics
CLDX
#4598
Rank
โ‚น227.04 B
Marketcap
โ‚น2,891
Share price
2.01%
Change (1 day)
21.68%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น6.55 Billion

According to Celldex Therapeutics's latest financial reports the company's total liabilities are โ‚น6.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น5.01 B28.84%
2024-12-31โ‚น3.88 B28.15%
2023-12-31โ‚น3.03 B38.24%
2022-12-31โ‚น2.19 B17.15%
2021-12-31โ‚น1.87 B-3.23%
2020-12-31โ‚น1.93 B-6.05%
2019-12-31โ‚น2.06 B-7.14%
2018-12-31โ‚น2.21 B-56.13%
2017-12-31โ‚น5.06 B-36.85%
2016-12-31โ‚น8.01 B153.98%
2015-12-31โ‚น3.15 B36.94%
2014-12-31โ‚น2.30 B36.61%
2013-12-31โ‚น1.68 B3.48%
2012-12-31โ‚น1.62 B5.25%
2011-12-31โ‚น1.54 B-0.38%
2010-12-31โ‚น1.55 B-49.7%
2009-12-31โ‚น3.09 B24.45%
2008-12-31โ‚น2.48 B502.19%
2007-12-31โ‚น0.41 B-84.31%
2006-12-31โ‚น2.62 B275.14%
2005-12-31โ‚น0.70 B118.65%
2004-12-31โ‚น0.32 B107.8%
2003-12-31โ‚น0.15 B-17.35%
2002-12-31โ‚น0.18 B-52.96%
2001-12-31โ‚น0.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚น11.185 T 170,496.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น8.120 T 123,748.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น5.711 T 87,008.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚น25.43 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น104.83 B 1,498.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น36.61 B 458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น75.00 B 1,043.91%๐Ÿ‡บ๐Ÿ‡ธ USA